Matinas Biopharma (MTNB)
(Delayed Data from AMEX)
$0.19 USD
0.00 (-1.21%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $0.19 0.00 (1.23%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 38% (96 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.52 | 9.99 |
Current Quarter Estimate | NA | -2.04 | 60.00 |
Year Ago Quarter Estimate | NA | -0.59 | 52.54 |
Next Quarter Estimate | NA | -2.00 | 61.00 |
Next Year Estimate | NA | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | NA | NA | NA |
Next Year | NA | NA | NA |
Last 5 Years | NA | NA | NA |
Next 5 Years | NA | NA | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 2.14 | 1.87 |
Price/Cash Flow (MRFY) | NA | 9.05 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -19.76% |
Return on Equity (TTM) | -89.20% | -72.91% |
Debt to Equity (MRQ) | NA | 0.30 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.